{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:30:53Z","timestamp":1787725853469,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>KDM6A is a critical part of the COMPASS-like complex. KDM6A deficiency may result in EZH2 dependency. KDM6A deficiency was analyzed by immunohistochemistry on a tissue microarray containing 14,814 samples from 153 different tumor entities and 76 different normal tissue types. In normal tissues, KDM6A staining was ubiquitously seen in nuclei. In tumors, KDM6A deficiency occurred in 58 of 153 tumor categories. KDM6A deficiency predominated in urothelial carcinomas (17.3\u201342.0%) and\u00a0was seen in 4\u201310% of gastric, pancreatic, prostatic, and gallbladder adenocarcinomas, serous endometrial carcinomas, squamous cell carcinomas, papillary renal cell carcinoma, hepatocellular carcinomas, malignant melanomas, and ovarian serous high-grade carcinomas. Reduced or absent KDM6A expression was associated with advanced pT stage (p\u2009=\u20090.0233), high grade (p\u2009=\u20090.0002), and distant metastasis (p\u2009=\u20090.0152) in breast cancer, nodal metastasis in squamous cell carcinomas (p\u2009=\u20090.0498), advanced pT stage (p\u2009=\u20090.0002), nodal metastasis (p\u2009=\u20090.0112), and mismatch repair deficiency (dMMR; p\u2009=\u20090.0147) in colorectal adenocarcinoma, and with dMMR (p\u2009=\u20090.0033) in gastric adenocarcinoma. KDM6A deficiency was significantly more common in tumors from males (4.3%) than from females (1.9%; p\u2009&lt;\u20090.0001). In summary, KDM6A deficiency predominates in urothelial neoplasms but also occurs in many further tumor entities. Whether KDM6A deficient cancers are susceptible to EZH2 inhibitors remains to be seen.<\/jats:p>","DOI":"10.1007\/s00428-026-04448-8","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:56:40Z","timestamp":1771354600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types"],"prefix":"10.1007","author":[{"given":"Florian","family":"Viehweger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gorbokon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Stichternath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Lennartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Reiswich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Krech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0158-4258","authenticated-orcid":false,"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hinsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Luebke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Menz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"von Bargen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Caneve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Schlichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Christina","family":"Tsourlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Wilczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till S.","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bernreuther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"4448_CR1","doi-asserted-by":"publisher","first-page":"63252","DOI":"10.18632\/oncotarget.11207","volume":"7","author":"J Ahn","year":"2016","unstructured":"Ahn J, Kim KH, Park S, Ahn YH, Kim HY, Yoon H, Lee JH, Bang D, Lee DH (2016) Target sequencing and CRISPR\/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer. Oncotarget 7:63252\u201363260. https:\/\/doi.org\/10.18632\/oncotarget.11207","journal-title":"Oncotarget"},{"key":"4448_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccell.2018.02.003","volume":"33","author":"J Andricovich","year":"2018","unstructured":"Andricovich J, Perkail S, Kai Y, Casasanta N, Peng W, Tzatsos A (2018) Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors. Cancer Cell 33:512-526 e518. https:\/\/doi.org\/10.1016\/j.ccell.2018.02.003","journal-title":"Cancer Cell"},{"key":"4448_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.893","volume":"195","author":"L Bubendorf","year":"2001","unstructured":"Bubendorf L, Nocito A, Moch H, Sauter G (2001) Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 195:72\u201379. https:\/\/doi.org\/10.1002\/path.893","journal-title":"J Pathol"},{"key":"4448_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08372-9","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Lin X, Pang G, Deng J, Xie Q, Zhang Z (2021) Significance of KDM6A mutation in bladder cancer immune escape. BMC Cancer 21:635. https:\/\/doi.org\/10.1186\/s12885-021-08372-9","journal-title":"BMC Cancer"},{"key":"4448_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111859","volume":"41","author":"TN Clinton","year":"2022","unstructured":"Clinton TN, Chen Z, Wise H, Lenis AT, Chavan S, Donoghue MTA, Almassi N, Chu CE, Dason S, Rao P, Rodrigues JA, Vasani NB, Ridouani F, Rosenberg JE, Bajorin DF, Teo MY, Bochner BH, Berger MF, Ostrovnaya I, Pietzak EJ, Iyer G, Gao SP, Hu W, Al-Ahmadie HA, Solit DB (2022) Genomic heterogeneity as a barrier to precision oncology in urothelial cancer. Cell Rep 41:111859. https:\/\/doi.org\/10.1016\/j.celrep.2022.111859","journal-title":"Cell Rep"},{"key":"4448_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"Consortium GT","year":"2013","unstructured":"Consortium GT (2013) The genotype-tissue expression (GTEx) project. Nat Genet 45:580\u2013585. https:\/\/doi.org\/10.1038\/ng.2653","journal-title":"Nat Genet"},{"key":"4448_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.celrep.2017.09.078","volume":"21","author":"T Ezponda","year":"2017","unstructured":"Ezponda T, Dupere-Richer D, Will CM, Small EC, Varghese N, Patel T, Nabet B, Popovic R, Oyer J, Bulic M, Zheng Y, Huang X, Shah MY, Maji S, Riva A, Occhionorelli M, Tonon G, Kelleher N, Keats J, Licht JD (2017) UTX\/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition. Cell Rep 21:628\u2013640. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.078","journal-title":"Cell Rep"},{"key":"4448_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/hmg\/7.4.737","volume":"7","author":"A Greenfield","year":"1998","unstructured":"Greenfield A, Carrel L, Pennisi D, Philippe C, Quaderi N, Siggers P, Steiner K, Tam PP, Monaco AP, Willard HF, Koopman P (1998) The UTX gene escapes X inactivation in mice and humans. Hum Mol Genet 7:737\u2013742. https:\/\/doi.org\/10.1093\/hmg\/7.4.737","journal-title":"Hum Mol Genet"},{"key":"4448_CR9","doi-asserted-by":"publisher","first-page":"18439","DOI":"10.1073\/pnas.0707292104","volume":"104","author":"S Hong","year":"2007","unstructured":"Hong S, Cho YW, Yu LR, Yu H, Veenstra TD, Ge K (2007) Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A 104:18439\u201318444. https:\/\/doi.org\/10.1073\/pnas.0707292104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4448_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.779918","volume":"11","author":"C Hua","year":"2021","unstructured":"Hua C, Chen J, Li S, Zhou J, Fu J, Sun W, Wang W (2021) KDM6 demethylases and their roles in human cancers. Front Oncol 11:779918. https:\/\/doi.org\/10.3389\/fonc.2021.779918","journal-title":"Front Oncol"},{"key":"4448_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2017.08.005","volume":"32","author":"CD Hurst","year":"2017","unstructured":"Hurst CD, Alder O, Platt FM, Droop A, Stead LF, Burns JE, Burghel GJ, Jain S, Klimczak LJ, Lindsay H, Roulson JA, Taylor CF, Thygesen H, Cameron AJ, Ridley AJ, Mott HR, Gordenin DA, Knowles MA (2017) Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency. Cancer Cell 32:701-715 e707. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.005","journal-title":"Cancer Cell"},{"key":"4448_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aar5598","volume":"4","author":"S Kaneko","year":"2018","unstructured":"Kaneko S, Li X (2018) X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism. Sci Adv 4:eaar5598. https:\/\/doi.org\/10.1126\/sciadv.aar5598","journal-title":"Sci Adv"},{"key":"4448_CR13","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1158\/1078-0432.CCR-19-2230","volume":"26","author":"K Kobatake","year":"2020","unstructured":"Kobatake K, Ikeda KI, Nakata Y, Yamasaki N, Ueda T, Kanai A, Sentani K, Sera Y, Hayashi T, Koizumi M, Miyakawa Y, Inaba T, Sotomaru Y, Kaminuma O, Ichinohe T, Honda ZI, Yasui W, Horie S, Black PC, Matsubara A, Honda H (2020) Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with p53 dysfunction. Clin Cancer Res 26:2065\u20132079. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2230","journal-title":"Clin Cancer Res"},{"key":"4448_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844\u2013847. https:\/\/doi.org\/10.1038\/nm0798-844","journal-title":"Nat Med"},{"key":"4448_CR15","doi-asserted-by":"publisher","unstructured":"Ler LD, Ghosh S, Chai X, Thike AA, Heng HL, Siew EY, Dey S, Koh LK, Lim JQ, Lim WK, Myint SS, Loh JL, Ong P, Sam XX, Huang D, Lim T, Tan PH, Nagarajan S, Cheng CW, Ho H, Ng LG, Yuen J, Lin PH, Chuang CK, Chang YH, Weng WH, Rozen SG, Tan P, Creasy CL, Pang ST, McCabe MT, Poon SL, Teh BT (2017) Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. Sci Transl Med 9. https:\/\/doi.org\/10.1126\/scitranslmed.aai8312","DOI":"10.1126\/scitranslmed.aai8312"},{"key":"4448_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01369-9","volume":"20","author":"L Liu","year":"2021","unstructured":"Liu L, Cui J, Zhao Y, Liu X, Chen L, Xia Y, Wang Y, Chen S, Sun S, Shi B, Zou Y (2021) KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1. Mol Cancer 20:77. https:\/\/doi.org\/10.1186\/s12943-021-01369-9","journal-title":"Mol Cancer"},{"key":"4448_CR17","doi-asserted-by":"publisher","first-page":"D752","DOI":"10.1093\/nar\/gky1099","volume":"47","author":"M Lizio","year":"2019","unstructured":"Lizio M, Abugessaisa I, Noguchi S, Kondo A, Hasegawa A, Hon CC, de Hoon M, Severin J, Oki S, Hayashizaki Y, Carninci P, Kasukawa T, Kawaji H (2019) Update of the FANTOM web resource: expansion to provide additional transcriptome atlases. Nucleic Acids Res 47:D752\u2013D758. https:\/\/doi.org\/10.1093\/nar\/gky1099","journal-title":"Nucleic Acids Res"},{"key":"4448_CR18","doi-asserted-by":"publisher","unstructured":"Lizio M, Harshbarger J, Shimoji H, Severin J, Kasukawa T, Sahin S, Abugessaisa I, Fukuda S, Hori F, Ishikawa-Kato S, Mungall CJ, Arner E, Baillie JK, Bertin N, Bono H, de Hoon M, Diehl AD, Dimont E, Freeman TC, Fujieda K, Hide W, Kaliyaperumal R, Katayama T, Lassmann T, Meehan TF, Nishikata K, Ono H, Rehli M, Sandelin A, Schultes EA, t Hoen PA, Tatum Z, Thompson M, Toyoda T, Wright DW, Daub CO, Itoh M, Carninci P, Hayashizaki Y, Forrest AR, Kawaji H, consortium F (2015) Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol 16:22. https:\/\/doi.org\/10.1186\/s13059-014-0560-6","DOI":"10.1186\/s13059-014-0560-6"},{"key":"4448_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00440-z","volume":"12","author":"D Luo","year":"2023","unstructured":"Luo D, Chen M, Li Q, Wang K, Wang K, Li J, Fu G, Shan Z, Liu Q, Yang Y, Liang L, Ma Y, Qin Y, Qin J, Gao D, Li X (2023) CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression. Exp Hematol Oncol 12:77. https:\/\/doi.org\/10.1186\/s40164-023-00440-z","journal-title":"Exp Hematol Oncol"},{"key":"4448_CR20","doi-asserted-by":"publisher","first-page":"62131","DOI":"10.18632\/oncotarget.19100","volume":"8","author":"VM Morozov","year":"2017","unstructured":"Morozov VM, Li Y, Clowers MM, Ishov AM (2017) Inhibitor of H3K27 demethylase JMJD3\/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer. Oncotarget 8:62131\u201362142. https:\/\/doi.org\/10.18632\/oncotarget.19100","journal-title":"Oncotarget"},{"key":"4448_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1158\/0008-5472.CAN-22-1444","volume":"83","author":"H Qiu","year":"2023","unstructured":"Qiu H, Makarov V, Bolzenius JK, Halstead A, Parker Y, Wang A, Iyer GV, Wise H, Kim D, Thayaparan V, Lindner DJ, Haber GP, Ting AH, Ren B, Chan TA, Arora V, Solit DB, Lee BH (2023) KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer. Cancer Res 83:814\u2013829. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1444","journal-title":"Cancer Res"},{"key":"4448_CR22","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41418-019-0278-9","volume":"26","author":"S Ramakrishnan","year":"2019","unstructured":"Ramakrishnan S, Granger V, Rak M, Hu Q, Attwood K, Aquila L, Krishnan N, Osiecki R, Azabdaftari G, Guru K, Chatta G, Gueron G, McNally L, Ohm J, Wang J, Woloszynska A (2019) Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death Differ 26:2100\u20132114. https:\/\/doi.org\/10.1038\/s41418-019-0278-9","journal-title":"Cell Death Differ"},{"key":"4448_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ijc.32116","volume":"145","author":"WA Schulz","year":"2019","unstructured":"Schulz WA, Lang A, Koch J, Greife A (2019) The histone demethylase UTX\/KDM6A in cancer: progress and puzzles. Int J Cancer 145:614\u2013620. https:\/\/doi.org\/10.1002\/ijc.32116","journal-title":"Int J Cancer"},{"key":"4448_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006661","volume":"13","author":"DR Soto","year":"2017","unstructured":"Soto DR, Barton C, Munger K, McLaughlin-Drubin ME (2017) KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress. PLoS Pathog 13:e1006661. https:\/\/doi.org\/10.1371\/journal.ppat.1006661","journal-title":"PLoS Pathog"},{"key":"4448_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal3321","author":"PJ Thul","year":"2017","unstructured":"Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, Alm T, Asplund A, Bjork L, Breckels LM, Backstrom A, Danielsson F, Fagerberg L, Fall J, Gatto L, Gnann C, Hober S, Hjelmare M, Johansson F, Lee S, Lindskog C, Mulder J, Mulvey CM, Nilsson P, Oksvold P, Rockberg J, Schutten R, Schwenk JM, Sivertsson A, Sjostedt E, Skogs M, Stadler C, Sullivan DP, Tegel H, Winsnes C, Zhang C, Zwahlen M, Mardinoglu A, Ponten F, von Feilitzen K, Lilley KS, Uhlen M, Lundberg E (2017) A subcellular map of the human proteome. Science. https:\/\/doi.org\/10.1126\/science.aal3321","journal-title":"Science"},{"key":"4448_CR26","doi-asserted-by":"publisher","unstructured":"Tran N, Broun A, Ge K (2020) Lysine demethylase KDM6A in differentiation, development, and cancer. Mol Cell Biol 40. https:\/\/doi.org\/10.1128\/MCB.00341-20","DOI":"10.1128\/MCB.00341-20"},{"key":"4448_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nmeth.3995","volume":"13","author":"M Uhlen","year":"2016","unstructured":"Uhlen M, Bandrowski A, Carr S, Edwards A, Ellenberg J, Lundberg E, Rimm DL, Rodriguez H, Hiltke T, Snyder M, Yamamoto T (2016) A proposal for validation of antibodies. Nat Methods 13:823\u2013827. https:\/\/doi.org\/10.1038\/nmeth.3995","journal-title":"Nat Methods"},{"key":"4448_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.32074\/1591-951X-1104","volume":"117","author":"F Viehweger","year":"2025","unstructured":"Viehweger F, Gorbokon N, Buyucek S, Plage H, Hofbauer S, Furlano K, Weinberger S, Ralla B, Fendler A, Biernath N, Erber B, Rossner F, Schallenberg S, Elezkurtaj S, Lennartz M, Bady E, Hube-Magg C, Marx AH, Samtleben H, Fisch M, Rink M, Zecha H, Slojewski M, Kaczmarek K, Ecke T, Koch S, Adamini N, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Kluth M, Minner S (2025) KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladder. Pathologica 117:296\u2013305. https:\/\/doi.org\/10.32074\/1591-951X-1104","journal-title":"Pathologica"},{"key":"4448_CR29","doi-asserted-by":"crossref","unstructured":"Viehweger F, Gorbokon n, B\u00fcy\u00fccek S, Plage H, Hofbauer S, Furlano K, Weinberger S, Ralla B, Fendler A, Biernath N, Erber B, Ro\u00dfner F, Schallenberg S, Elezkurtaj S, Lennartz M, Bady E, Hube-Magg C, Marx AH, Samtleben H, Fisch M, Rink M, Zecha H, Slojewski M, Kaczmarek K, Ecke T, Koch S, Adamini N, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Kluth M, Minner S (2024) KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladder. Pathologica in press","DOI":"10.32074\/1591-951X-1104"},{"key":"4448_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/biolre\/ioad141","volume":"110","author":"BW Walters","year":"2024","unstructured":"Walters BW, Rainsford SR, Heuer RA, Dias N, Huang X, de Rooij D, Lesch BJ (2024) KDM6A\/UTX promotes spermatogenic gene expression across generations and is not required for male fertilitydagger. Biol Reprod 110:391\u2013407. https:\/\/doi.org\/10.1093\/biolre\/ioad141","journal-title":"Biol Reprod"},{"key":"4448_CR31","doi-asserted-by":"publisher","first-page":"E3978","DOI":"10.1073\/pnas.1716589115","volume":"115","author":"Q Wu","year":"2018","unstructured":"Wu Q, Tian Y, Zhang J, Tong X, Huang H, Li S, Zhao H, Tang Y, Yuan C, Wang K, Fang Z, Gao L, Hu X, Li F, Qin Z, Yao S, Chen T, Chen H, Zhang G, Liu W, Sun Y, Chen L, Wong KK, Ge K, Chen L, Ji H (2018) In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis. Proc Natl Acad Sci U S A 115:E3978\u2013E3986. https:\/\/doi.org\/10.1073\/pnas.1716589115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4448_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1158\/1541-7786.MCR-21-0402","volume":"20","author":"JF Xiao","year":"2022","unstructured":"Xiao JF, Kua LF, Ding LW, Sun QY, Myint KN, Chia XR, Venkatachalam N, Loh X, Duex JE, Neang V, Zhou S, Li Y, Yang H, Koeffler HP, Theodorescu D (2022) KDM6A depletion in breast epithelial cells leads to reduced sensitivity to anticancer agents and increased TGFbeta activity. Mol Cancer Res 20:637\u2013649. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0402","journal-title":"Mol Cancer Res"},{"key":"4448_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-020-00359-3","volume":"13","author":"B Xu","year":"2020","unstructured":"Xu B, Mulvey B, Salie M, Yang X, Matsui Y, Nityanandam A, Fan Y, Peng JC (2020) UTX\/KDM6A suppresses AP-1 and a gliogenesis program during neural differentiation of human pluripotent stem cells. Epigenetics Chromatin 13:38. https:\/\/doi.org\/10.1186\/s13072-020-00359-3","journal-title":"Epigenetics Chromatin"},{"key":"4448_CR34","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","volume":"29","author":"M Yamagishi","year":"2019","unstructured":"Yamagishi M, Hori M, Fujikawa D, Ohsugi T, Honma D, Adachi N, Katano H, Hishima T, Kobayashi S, Nakano K, Nakashima M, Iwanaga M, Utsunomiya A, Tanaka Y, Okada S, Tsukasaki K, Tobinai K, Araki K, Watanabe T, Uchimaru K (2019) Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in malignant lymphomas. Cell Rep 29:2321-2337 e2327. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.083","journal-title":"Cell Rep"},{"key":"4448_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J, Mandelker DL, Cheng DT, Chandramohan R, Mohanty AS, Ptashkin RN, Jayakumaran G, Prasad M, Syed MH, Rema AB, Liu ZY, Nafa K, Borsu L, Sadowska J, Casanova J, Bacares R, Kiecka IJ, Razumova A, Son JB, Stewart L, Baldi T, Mullaney KA, Al-Ahmadie H, Vakiani E, Abeshouse AA, Penson AV, Jonsson P, Camacho N, Chang MT, Won HH, Gross BE, Kundra R, Heins ZJ, Chen HW, Phillips S, Zhang H, Wang J, Ochoa A, Wills J, Eubank M, Thomas SB, Gardos SM, Reales DN, Galle J, Durany R, Cambria R, Abida W, Cercek A, Feldman DR, Gounder MM, Hakimi AA, Harding JJ, Iyer G, Janjigian YY, Jordan EJ, Kelly CM, Lowery MA, Morris LGT, Omuro AM, Raj N, Razavi P, Shoushtari AN, Shukla N, Soumerai TE, Varghese AM, Yaeger R, Coleman J, Bochner B, Riely GJ, Saltz LB, Scher HI, Sabbatini PJ, Robson ME, Klimstra DS, Taylor BS, Baselga J, Schultz N, Hyman DM, Arcila ME, Solit DB, Ladanyi M, Berger MF (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23:703\u2013713. https:\/\/doi.org\/10.1038\/nm.4333","journal-title":"Nat Med"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04448-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:56:41Z","timestamp":1771354601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04448-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":35,"alternative-id":["4448"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04448-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of archived remnants of diagnostic tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, \u00a712) and by the local ethics committee (Ethics commission Hamburg, WF-049\/09). All work has been carried out in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Rabbit recombinant monoclonal antibody, clone HMV311 was provided from ardoci GmbH (owned by a family member of GS).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}